Projects per year
Abstract
COPD, a leading cause of mortality is currently assessed by spirometry (forced expiratory volume in 1 second, FEV(1)). However FEV(1) does not correlate with patient mortality. ECLIPSE (Evaluation of Chronic obstructive pulmonary disease to Longitudinally Identify Predictive Surrogate Endpoints) aims to identify biomarkers that correlate with clinically relevant COPD subtypes, and to assess how these may predict disease progression. New methods were developed and validated to evaluate small molecules as potential diagnostic tools in patients with COPD, COPD related cachexia and cancer related cachexia.
Original language | English |
---|---|
Pages (from-to) | 3125-33 |
Number of pages | 9 |
Journal | Molecular BioSystems |
Volume | 8 |
Issue number | 12 |
DOIs | |
Publication status | Published - 30 Oct 2012 |
Keywords / Materials (for Non-textual outputs)
- Aged
- Amino Acids
- Biological Markers
- Body Mass Index
- Cachexia
- Disease Progression
- Female
- Humans
- Longitudinal Studies
- Male
- Metabolomics
- Middle Aged
- Pancreatic Neoplasms
- Pulmonary Disease, Chronic Obstructive
- Pulmonary Emphysema
- Respiratory Function Tests
- Severity of Illness Index
- Smoking
- Tandem Mass Spectrometry
- gamma-Aminobutyric Acid
Fingerprint
Dive into the research topics of 'Targeted metabolomics identifies perturbations in amino acid metabolism that sub-classify patients with COPD'. Together they form a unique fingerprint.Projects
- 1 Finished
-
PhD STUDENT - JOANNE SIMPSON - Supervisor MOHINI GRAY
Iredale, J. (Principal Investigator)
1/09/12 → 31/08/16
Project: Research